BE1001044A5 - Composition pour induire et stimuler la croissance des cheveux et diminuer leur chute a base de derives de la pyrimidine. - Google Patents
Composition pour induire et stimuler la croissance des cheveux et diminuer leur chute a base de derives de la pyrimidine. Download PDFInfo
- Publication number
- BE1001044A5 BE1001044A5 BE8700870A BE8700870A BE1001044A5 BE 1001044 A5 BE1001044 A5 BE 1001044A5 BE 8700870 A BE8700870 A BE 8700870A BE 8700870 A BE8700870 A BE 8700870A BE 1001044 A5 BE1001044 A5 BE 1001044A5
- Authority
- BE
- Belgium
- Prior art keywords
- sep
- composition
- composition according
- chosen
- formula
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 54
- CZPWVGJYEJSRLH-UHFFFAOYSA-N Pyrimidine Chemical compound C1=CN=CN=C1 CZPWVGJYEJSRLH-UHFFFAOYSA-N 0.000 title claims description 11
- 230000003779 hair growth Effects 0.000 title claims description 8
- 230000006698 induction Effects 0.000 title claims description 3
- 150000001875 compounds Chemical class 0.000 claims abstract description 29
- 125000000217 alkyl group Chemical group 0.000 claims abstract description 9
- 229910052739 hydrogen Inorganic materials 0.000 claims abstract description 7
- 239000001257 hydrogen Substances 0.000 claims abstract description 7
- 125000003342 alkenyl group Chemical group 0.000 claims abstract description 6
- 125000002877 alkyl aryl group Chemical group 0.000 claims abstract description 6
- 125000000753 cycloalkyl group Chemical group 0.000 claims abstract description 6
- 125000000623 heterocyclic group Chemical group 0.000 claims abstract description 5
- 125000003118 aryl group Chemical group 0.000 claims abstract description 4
- 125000005055 alkyl alkoxy group Chemical group 0.000 claims abstract description 3
- 125000004948 alkyl aryl alkyl group Chemical group 0.000 claims abstract description 3
- 125000003710 aryl alkyl group Chemical group 0.000 claims abstract description 3
- 125000002034 haloarylalkyl group Chemical group 0.000 claims abstract description 3
- 229910052757 nitrogen Inorganic materials 0.000 claims abstract description 3
- 125000004433 nitrogen atom Chemical group N* 0.000 claims abstract description 3
- 125000004435 hydrogen atom Chemical class [H]* 0.000 claims abstract 4
- 210000004209 hair Anatomy 0.000 claims description 24
- 239000002245 particle Substances 0.000 claims description 19
- 239000002609 medium Substances 0.000 claims description 18
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 claims description 15
- 229920002125 Sokalan® Polymers 0.000 claims description 13
- 201000004384 Alopecia Diseases 0.000 claims description 12
- 239000002562 thickening agent Substances 0.000 claims description 12
- 239000000725 suspension Substances 0.000 claims description 11
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 9
- 230000003676 hair loss Effects 0.000 claims description 9
- 150000003839 salts Chemical class 0.000 claims description 9
- 208000024963 hair loss Diseases 0.000 claims description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 8
- 229920003145 methacrylic acid copolymer Polymers 0.000 claims description 7
- 239000002904 solvent Substances 0.000 claims description 7
- 125000004432 carbon atom Chemical group C* 0.000 claims description 6
- 239000000178 monomer Substances 0.000 claims description 6
- 150000003230 pyrimidines Chemical class 0.000 claims description 6
- 210000004761 scalp Anatomy 0.000 claims description 6
- 125000000129 anionic group Chemical group 0.000 claims description 5
- 239000012736 aqueous medium Substances 0.000 claims description 5
- 229920001577 copolymer Polymers 0.000 claims description 5
- 239000002537 cosmetic Substances 0.000 claims description 5
- 230000012010 growth Effects 0.000 claims description 5
- 238000000034 method Methods 0.000 claims description 5
- 229920000642 polymer Polymers 0.000 claims description 5
- 229940083082 pyrimidine derivative acting on arteriolar smooth muscle Drugs 0.000 claims description 5
- YNAVUWVOSKDBBP-UHFFFAOYSA-N Morpholine Chemical compound C1COCCN1 YNAVUWVOSKDBBP-UHFFFAOYSA-N 0.000 claims description 4
- 239000013543 active substance Substances 0.000 claims description 4
- 229920006317 cationic polymer Polymers 0.000 claims description 4
- 229920002678 cellulose Polymers 0.000 claims description 4
- 239000001913 cellulose Substances 0.000 claims description 4
- 230000001939 inductive effect Effects 0.000 claims description 4
- 230000003993 interaction Effects 0.000 claims description 4
- 230000008569 process Effects 0.000 claims description 4
- 125000001453 quaternary ammonium group Chemical group 0.000 claims description 4
- 230000004936 stimulating effect Effects 0.000 claims description 4
- CERQOIWHTDAKMF-UHFFFAOYSA-N Methacrylic acid Chemical compound CC(=C)C(O)=O CERQOIWHTDAKMF-UHFFFAOYSA-N 0.000 claims description 3
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 claims description 3
- 239000002253 acid Substances 0.000 claims description 3
- -1 alkylene glycols Chemical class 0.000 claims description 3
- 150000002334 glycols Chemical class 0.000 claims description 3
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 claims description 3
- 239000011976 maleic acid Substances 0.000 claims description 3
- 125000003386 piperidinyl group Chemical group 0.000 claims description 3
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 claims description 3
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 claims description 2
- 239000005977 Ethylene Substances 0.000 claims description 2
- WHNWPMSKXPGLAX-UHFFFAOYSA-N N-Vinyl-2-pyrrolidone Chemical compound C=CN1CCCC1=O WHNWPMSKXPGLAX-UHFFFAOYSA-N 0.000 claims description 2
- 150000007513 acids Chemical class 0.000 claims description 2
- 150000001252 acrylic acid derivatives Chemical class 0.000 claims description 2
- 150000001298 alcohols Chemical class 0.000 claims description 2
- 150000005215 alkyl ethers Chemical class 0.000 claims description 2
- 238000000149 argon plasma sintering Methods 0.000 claims description 2
- 125000002393 azetidinyl group Chemical group 0.000 claims description 2
- 125000004069 aziridinyl group Chemical group 0.000 claims description 2
- QXNDZONIWRINJR-UHFFFAOYSA-N azocane Chemical compound C1CCCNCCC1 QXNDZONIWRINJR-UHFFFAOYSA-N 0.000 claims description 2
- NRHDCQLCSOWVTF-UHFFFAOYSA-N azonane Chemical compound C1CCCCNCCC1 NRHDCQLCSOWVTF-UHFFFAOYSA-N 0.000 claims description 2
- 239000003795 chemical substances by application Substances 0.000 claims description 2
- YIOJGTBNHQAVBO-UHFFFAOYSA-N dimethyl-bis(prop-2-enyl)azanium Chemical compound C=CC[N+](C)(C)CC=C YIOJGTBNHQAVBO-UHFFFAOYSA-N 0.000 claims description 2
- 125000004634 hexahydroazepinyl group Chemical group N1(CCCCCC1)* 0.000 claims description 2
- 229920001519 homopolymer Polymers 0.000 claims description 2
- 229920013821 hydroxy alkyl cellulose Polymers 0.000 claims description 2
- FPYJFEHAWHCUMM-UHFFFAOYSA-N maleic anhydride Chemical compound O=C1OC(=O)C=C1 FPYJFEHAWHCUMM-UHFFFAOYSA-N 0.000 claims description 2
- 238000002360 preparation method Methods 0.000 claims description 2
- 125000000719 pyrrolidinyl group Chemical group 0.000 claims description 2
- 230000000638 stimulation Effects 0.000 claims description 2
- DGXNWWJYEMQHED-UHFFFAOYSA-N trimethyl-(4-methyl-3-oxopent-4-enyl)azanium Chemical class CC(=C)C(=O)CC[N+](C)(C)C DGXNWWJYEMQHED-UHFFFAOYSA-N 0.000 claims description 2
- VZTGWJFIMGVKSN-UHFFFAOYSA-O trimethyl-[3-(2-methylprop-2-enoylamino)propyl]azanium Chemical compound CC(=C)C(=O)NCCC[N+](C)(C)C VZTGWJFIMGVKSN-UHFFFAOYSA-O 0.000 claims description 2
- 239000003814 drug Substances 0.000 claims 2
- HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 claims 1
- 125000005113 hydroxyalkoxy group Chemical group 0.000 claims 1
- 150000002734 metacrylic acid derivatives Chemical class 0.000 claims 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 11
- 230000003698 anagen phase Effects 0.000 description 7
- 239000000243 solution Substances 0.000 description 7
- 235000019441 ethanol Nutrition 0.000 description 6
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 4
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 231100000360 alopecia Toxicity 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 230000031774 hair cycle Effects 0.000 description 3
- 239000004584 polyacrylic acid Substances 0.000 description 3
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 3
- SOGAXMICEFXMKE-UHFFFAOYSA-N Butylmethacrylate Chemical compound CCCCOC(=O)C(C)=C SOGAXMICEFXMKE-UHFFFAOYSA-N 0.000 description 2
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 2
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 2
- VVQNEPGJFQJSBK-UHFFFAOYSA-N Methyl methacrylate Chemical compound COC(=O)C(C)=C VVQNEPGJFQJSBK-UHFFFAOYSA-N 0.000 description 2
- NJSSICCENMLTKO-HRCBOCMUSA-N [(1r,2s,4r,5r)-3-hydroxy-4-(4-methylphenyl)sulfonyloxy-6,8-dioxabicyclo[3.2.1]octan-2-yl] 4-methylbenzenesulfonate Chemical compound C1=CC(C)=CC=C1S(=O)(=O)O[C@H]1C(O)[C@@H](OS(=O)(=O)C=2C=CC(C)=CC=2)[C@@H]2OC[C@H]1O2 NJSSICCENMLTKO-HRCBOCMUSA-N 0.000 description 2
- 125000003545 alkoxy group Chemical group 0.000 description 2
- 230000003778 catagen phase Effects 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- 150000002431 hydrogen Chemical class 0.000 description 2
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 2
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 239000003755 preservative agent Substances 0.000 description 2
- QQONPFPTGQHPMA-UHFFFAOYSA-N propylene Natural products CC=C QQONPFPTGQHPMA-UHFFFAOYSA-N 0.000 description 2
- 125000004805 propylene group Chemical group [H]C([H])([H])C([H])([*:1])C([H])([H])[*:2] 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 230000003797 telogen phase Effects 0.000 description 2
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 description 1
- HJYFDPLDTAKBMR-UHFFFAOYSA-N 2-amino-4-piperidin-1-ylpyrimidin-5-ol Chemical compound NC1=NC=C(O)C(N2CCCCC2)=N1 HJYFDPLDTAKBMR-UHFFFAOYSA-N 0.000 description 1
- 206010003694 Atrophy Diseases 0.000 description 1
- LCGLNKUTAGEVQW-UHFFFAOYSA-N Dimethyl ether Chemical compound COC LCGLNKUTAGEVQW-UHFFFAOYSA-N 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- XLYMOEINVGRTEX-ARJAWSKDSA-N Ethyl hydrogen fumarate Chemical compound CCOC(=O)\C=C/C(O)=O XLYMOEINVGRTEX-ARJAWSKDSA-N 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- CERQOIWHTDAKMF-UHFFFAOYSA-M Methacrylate Chemical compound CC(=C)C([O-])=O CERQOIWHTDAKMF-UHFFFAOYSA-M 0.000 description 1
- ZFMITUMMTDLWHR-UHFFFAOYSA-N Minoxidil Chemical compound NC1=[N+]([O-])C(N)=CC(N2CCCCC2)=N1 ZFMITUMMTDLWHR-UHFFFAOYSA-N 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- 239000002535 acidifier Substances 0.000 description 1
- 150000003926 acrylamides Chemical class 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 238000005054 agglomeration Methods 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 229920006318 anionic polymer Polymers 0.000 description 1
- 239000007900 aqueous suspension Substances 0.000 description 1
- 230000037444 atrophy Effects 0.000 description 1
- 239000002610 basifying agent Substances 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000008827 biological function Effects 0.000 description 1
- 230000007321 biological mechanism Effects 0.000 description 1
- 239000008139 complexing agent Substances 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 1
- 238000009837 dry grinding Methods 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 230000002500 effect on skin Effects 0.000 description 1
- 230000002124 endocrine Effects 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 238000001033 granulometry Methods 0.000 description 1
- 125000004356 hydroxy functional group Chemical group O* 0.000 description 1
- 238000002513 implantation Methods 0.000 description 1
- 239000002085 irritant Substances 0.000 description 1
- 231100000021 irritant Toxicity 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 229960003632 minoxidil Drugs 0.000 description 1
- 230000000394 mitotic effect Effects 0.000 description 1
- 239000004570 mortar (masonry) Substances 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 239000012047 saturated solution Substances 0.000 description 1
- 239000002453 shampoo Substances 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 210000000434 stratum corneum Anatomy 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- 230000001131 transforming effect Effects 0.000 description 1
- 230000001052 transient effect Effects 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
- A61K8/4953—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom containing pyrimidine ring derivatives, e.g. minoxidil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/731—Cellulose; Quaternized cellulose derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/81—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
- A61K8/8141—Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by only one carboxyl radical, or of salts, anhydrides, esters, amides, imides or nitriles thereof; Compositions of derivatives of such polymers
- A61K8/8147—Homopolymers or copolymers of acids; Metal or ammonium salts thereof, e.g. crotonic acid, (meth)acrylic acid; Compositions of derivatives of such polymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q7/00—Preparations for affecting hair growth
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Cosmetics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| LU86547A LU86547A1 (fr) | 1986-08-07 | 1986-08-07 | Suspension pour induire et stimuler la croissance des cheveux et diminuer leur chute a base de derives de la pyrimidine |
| AT269387A AT400515B (de) | 1986-08-07 | 1987-10-12 | Pharmazeutisches mittel zur förderung und stimulierung des haarwachstums und zur verringerung von haarausfall auf basis von pyrimidinderivaten, sowie verwendung des mittels |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BE1001044A5 true BE1001044A5 (fr) | 1989-06-20 |
Family
ID=25598930
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BE8700870A BE1001044A5 (fr) | 1986-08-07 | 1987-08-06 | Composition pour induire et stimuler la croissance des cheveux et diminuer leur chute a base de derives de la pyrimidine. |
Country Status (13)
| Country | Link |
|---|---|
| JP (1) | JPS6344512A (enExample) |
| AT (1) | AT400515B (enExample) |
| AU (1) | AU608763B2 (enExample) |
| BE (1) | BE1001044A5 (enExample) |
| CA (1) | CA1294882C (enExample) |
| CH (1) | CH675965A5 (enExample) |
| DE (1) | DE3726177A1 (enExample) |
| DK (1) | DK168190B1 (enExample) |
| FR (1) | FR2602424B1 (enExample) |
| GB (1) | GB2194887B (enExample) |
| LU (1) | LU86547A1 (enExample) |
| NL (1) | NL8701853A (enExample) |
| SE (1) | SE503269C2 (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| LU86574A1 (fr) * | 1986-09-08 | 1988-04-05 | Oreal | Composition pour induire et stimuler la croissance des cheveux et freiner leur chute,a base d'esters nicotiniques et de derives de pyrimidine |
| JP2675111B2 (ja) * | 1988-02-18 | 1997-11-12 | ジ・アップジョン・カンパニー | ミノキシジルゲル |
| US5225189A (en) * | 1988-02-18 | 1993-07-06 | The Upjohn Company | Minoxidil gel |
| ATE90195T1 (de) * | 1988-02-18 | 1993-06-15 | Upjohn Co | Minoxidil-gel. |
| US7442369B1 (en) * | 2000-08-09 | 2008-10-28 | Mcneil Ab | Compositions of minoxidil |
| JP2023031353A (ja) * | 2021-08-25 | 2023-03-09 | 学校法人近畿大学 | 毛包上皮幹細胞活性化剤及び外用組成物 |
Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2347044A1 (fr) * | 1976-04-05 | 1977-11-04 | Scherico Ltd | Compositions pharmaceutiques contenant comme ingredients actifs des derives de triazolo-pyrimidines utiles pour le traitement de psoriasis |
| DE2804519A1 (de) * | 1977-02-04 | 1978-08-10 | Hoffmann La Roche | Oxadiazolopyrimidin-derivate |
| US4139619A (en) * | 1976-05-24 | 1979-02-13 | The Upjohn Company | 6-Amino-4-(substituted amino)-1,2-dihydro-1-hydroxy-2-iminopyrimidine, topical compositions and process for hair growth |
| GB2136689A (en) * | 1983-03-23 | 1984-09-26 | Oreal | Thickened or gelled composition for conditioning hair |
| EP0188793A1 (en) * | 1984-12-21 | 1986-07-30 | Richardson-Vicks, Inc. | Improved topical minoxidil composition |
| FR2590897A1 (fr) * | 1985-12-06 | 1987-06-05 | Kemyos Bio Medical Research Sr | Nouveaux derives de 6 amino 1,2-dihydro-1-hydroxy-2-imino-pyrimidine, leur procede de preparation et compositions cosmetiques les renfermant |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3461461A (en) * | 1965-11-01 | 1969-08-12 | Upjohn Co | 6-amino-4-(substituted amino)-1,2-dihydro-1-hydroxy-2-iminopyrimidines |
| CA1020558A (en) * | 1971-04-07 | 1977-11-08 | Richard C. Thomas (Jr.) | 6-amino-4-(substituted amino)-1,2-dihydro-1-hydroxy-2-iminopyrimidines |
| DE3584595D1 (de) * | 1984-08-29 | 1991-12-12 | Kao Corp | Antimikrobische suspensionen und antimikrobische haarbehandlungsmittel. |
| IT1201436B (it) * | 1985-07-19 | 1989-02-02 | Vincenzo Zappia | Formulazioni topiche a lento rilascio |
| DE3615396A1 (de) * | 1986-05-07 | 1987-11-12 | Wella Ag | Mittel zur behandlung der haare und der kopfhaut |
-
1986
- 1986-08-07 LU LU86547A patent/LU86547A1/fr unknown
-
1987
- 1987-08-05 CH CH3010/87A patent/CH675965A5/fr not_active IP Right Cessation
- 1987-08-06 FR FR878711207A patent/FR2602424B1/fr not_active Expired - Lifetime
- 1987-08-06 AU AU76619/87A patent/AU608763B2/en not_active Ceased
- 1987-08-06 SE SE8703068A patent/SE503269C2/sv not_active IP Right Cessation
- 1987-08-06 GB GB8718612A patent/GB2194887B/en not_active Expired - Lifetime
- 1987-08-06 DE DE19873726177 patent/DE3726177A1/de active Granted
- 1987-08-06 NL NL8701853A patent/NL8701853A/nl not_active Application Discontinuation
- 1987-08-06 CA CA000543885A patent/CA1294882C/fr not_active Expired - Lifetime
- 1987-08-06 BE BE8700870A patent/BE1001044A5/fr not_active IP Right Cessation
- 1987-08-07 JP JP62198011A patent/JPS6344512A/ja active Pending
- 1987-08-07 DK DK413687A patent/DK168190B1/da not_active IP Right Cessation
- 1987-10-12 AT AT269387A patent/AT400515B/de not_active IP Right Cessation
Patent Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2347044A1 (fr) * | 1976-04-05 | 1977-11-04 | Scherico Ltd | Compositions pharmaceutiques contenant comme ingredients actifs des derives de triazolo-pyrimidines utiles pour le traitement de psoriasis |
| US4139619A (en) * | 1976-05-24 | 1979-02-13 | The Upjohn Company | 6-Amino-4-(substituted amino)-1,2-dihydro-1-hydroxy-2-iminopyrimidine, topical compositions and process for hair growth |
| DE2804519A1 (de) * | 1977-02-04 | 1978-08-10 | Hoffmann La Roche | Oxadiazolopyrimidin-derivate |
| GB2136689A (en) * | 1983-03-23 | 1984-09-26 | Oreal | Thickened or gelled composition for conditioning hair |
| EP0188793A1 (en) * | 1984-12-21 | 1986-07-30 | Richardson-Vicks, Inc. | Improved topical minoxidil composition |
| FR2590897A1 (fr) * | 1985-12-06 | 1987-06-05 | Kemyos Bio Medical Research Sr | Nouveaux derives de 6 amino 1,2-dihydro-1-hydroxy-2-imino-pyrimidine, leur procede de preparation et compositions cosmetiques les renfermant |
Also Published As
| Publication number | Publication date |
|---|---|
| SE8703068D0 (sv) | 1987-08-06 |
| AU608763B2 (en) | 1991-04-18 |
| CA1294882C (fr) | 1992-01-28 |
| NL8701853A (nl) | 1988-03-01 |
| DE3726177C2 (enExample) | 1992-04-09 |
| DK413687A (da) | 1988-02-08 |
| FR2602424B1 (fr) | 1991-08-16 |
| CH675965A5 (enExample) | 1990-11-30 |
| DK168190B1 (da) | 1994-02-28 |
| SE8703068L (sv) | 1988-02-08 |
| AU7661987A (en) | 1988-02-11 |
| GB2194887A (en) | 1988-03-23 |
| GB2194887B (en) | 1991-01-30 |
| FR2602424A1 (fr) | 1988-02-12 |
| ATA269387A (de) | 1995-06-15 |
| JPS6344512A (ja) | 1988-02-25 |
| DE3726177A1 (de) | 1988-02-11 |
| AT400515B (de) | 1996-01-25 |
| GB8718612D0 (en) | 1987-09-09 |
| DK413687D0 (da) | 1987-08-07 |
| SE503269C2 (sv) | 1996-04-29 |
| LU86547A1 (fr) | 1988-03-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0780115B1 (fr) | Nanoparticules enrobées d'une phase lamellaire à base de tensioactif siliconé et compositions les contenant | |
| LU87187A1 (fr) | Association de derives de pyrimidine et de derives d'acide salicylique pour induire et stimuler la croissance des cheveux et diminuer leur chute | |
| FR2607505A1 (fr) | Nouveaux derives de piperazinyl-1 pyrimidine, leur preparation et leur application en therapeutique et cosmetique | |
| BE1001045A5 (fr) | Composition sous forme de gel pour induire et stimuler la croissance des cheveux et diminuer leur chute a base de derives de piperidino-pyrimidine. | |
| EP0913147B1 (fr) | Système à base de dérivé d'acide phosphonique et de métabisulfite pour stabiliser l'acide ascorbique | |
| CA1294883C (fr) | Composition pour induire et stimuler la croissance des cheveux et freiner leur chute a base d'esters nicotiniques et de derives de pyrimidine | |
| FR2722097A1 (fr) | Composition cosmetique et/ou dermatologique gelifiee, riche en solvant et contenant des particules creuses, ses application | |
| BE1001044A5 (fr) | Composition pour induire et stimuler la croissance des cheveux et diminuer leur chute a base de derives de la pyrimidine. | |
| CA2330332A1 (fr) | Composition cosmetique comprenant un derive d'aminophenol | |
| EP0357484B1 (fr) | Composition pour induire et stimuler la croissance des cheveux et/ou freiner leur chute, à base d'alkyl-polyglycoside et d'un dérivé de pyrimidine | |
| CA1341265C (fr) | Association a base de derives de pyrimidine et d'antagonistes de calcium en vue d'induire et de stimuler la croissance des cheveux et diminuer leur chute | |
| BE1000621A3 (fr) | Composition pour induire et stimuler la croissance des cheveux et diminuer la chute a base de derives d'alkylene diamino quinazoline. | |
| EP0680748A1 (fr) | Composition cosmétique et/ou dermatologique à gélifiant polymèrique cationique, ses utilisations notamment pour la dépigmentation de la peau | |
| EP0679388A1 (fr) | Composition cosmetique et/ou dermatologique notamment pour dépigmenter la peau, ses utilisations | |
| FR3059329A1 (fr) | Dispersion aqueuse de polymere supramoleculaire polyalcene et son utilisation en cosmetique | |
| FR3053334A1 (fr) | Melange liquide contenant du 4-(3-ethoxy-4-hydroxyphenyl)butan-2-one et de compose de xanthine | |
| CA1302287C (fr) | Composition pour induire et stimuler la croissance des cheveux et diminuer la chute a base de derives de piperidino-pyrimidine | |
| FR2779053A1 (fr) | Association de derives de pyrimidine et de derives azoles pour induire et/ou stimuler la croissance des cheveux et/ou diminuer leur chute | |
| EP0319991A1 (fr) | Association de dérivés de pyrimidine et d'agents antibactériens pour induire et stimuler la croissance des cheveux et diminuer leur chute | |
| PT85488B (pt) | Processo para a preparacao de uma composicao para induzir e estimular o crescimento dos cabelos e diminuir a queda destes, com base em derivados da pirimidina |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RE | Patent lapsed |
Effective date: 20030831 |